Pharmiweb.com RSS Feeds 
PharmiWeb Candidate Blog
Features
.jpg)
18 Jun 09
Field reporter Rhonda Siddall reports from EULAR
Rhonda Siddall - Pharmiweb Field Reporter
16 Jun 09
Quick Look article from Max Golby about Alternative Therapies
Max Golby
15 Jun 09
Unless it paints the right picture you’re letting the side down!
In a depressed job market, an employer is likely to receive 50+ CVs per job advertised from 5 or more Preferred Agencies and many more from agencies who ‘piggy back’ in. So now, more than ever, your CV needs to stand out and be tailored to the role and client and submitted by an agency with valid access.
Avril Horn PhD
11 Jun 09
Dr Wolfgang Wein, Executive Vice-President of Merck Serono’s Oncology Business comments on the recent final appraisal determination by NICE paving the way for its leading oncology product Erbitux to benefit UK mCRC patients.
Olwen Glynn Owen - Pharmiweb Field reporter
03 Jun 09
Quick Look article written by Max Golby, focusing on topic of swine flu.
Max Golby
20 May 09
Senior Department of Health executives, speaking at a recent NHS Alliance Conference, suggested that the NHS has two years left before it starts to the credit crunch’s bite – maybe less if there is an election in a years’ time. But this should not be cause complacency in the health sector. The message is, invest wisely now so that you are well prepared for the fallow times ahead.
PDC Healthcare
18 May 09
The growing incidence of diseases and conditions related to aging is creating pockets of opportunity for pain management. These opportunities include the expanding use of prescription NSAIDs as second-line therapies for chronic pain and an increase in off-label prescribing. As populations and indications evolve, so too is the pain management sector.
Applied Data Research
.jpg)
14 May 09
In this edition of StrategicEdge, CBR Pharma Insights discusses the current trends and opportunities that exist in marketing to consumers as the age of TiVo, DVRs, and cost constraints point the industry towards creative uses of the internet and other e-technologies.
CBR Pharma Insights
.gif)
11 May 09
The recent outbreak of influenza A (H1N1) infection, previously referred to as swine flu, has thrown the spotlight on governments around the world and their ability to manage a pandemic. In the UAE, customers are currently finding it difficult to source antivirals but, with Dubai seen as a hub for international travel, the government has stockpiles ready for distribution should an outbreak occur.
Datamonitor
08 May 09
There has been no shortage of conversation lately about current problems facing the Pharmaceutical industry...
Fred Beadon
05 May 09
As part of the UK government's drive to save over GBP2 billion in the NHS during 2010-11, GBP550m will be cut from the prices of branded drugs as a result of the revised Pharmaceutical Price Regulation Scheme. With the volume of branded drugs having remained flat over the last four years, total sales of the UK branded pharmaceutical industry are forecast to decline from 2009 onwards.
Editor
30 Apr 09
Where the pharmaceutical industry is often said to be immune to economic depression, the current economic crisis cannot be considered a direct historical equal to the recessions of the past.
Max Golby
28 Apr 09
Public opinion has for long been regarded as essential to the success of a thriving business. In fact, whilst the benefits of popular perception can often appear somewhat intangible on the balance sheet, what is essentially the respect of the customer is the bastion of almost every profession
Max Golby
.jpg)
20 Apr 09
Despite the current economic downturn, pharmaceutical research & development spending continues to play a vital role in the pharmaceutical industry. The industry, as a whole, needs to find new, more innovative ways to compensate for the recent and upcoming patent loses of many blockbusters products...
CBR Pharma Insights
20 Apr 09
Any positive effect on the pharmaceutical industry derived from the G20 summit and European Union summit will be indirect and much of the direct healthcare spending increase will cover the cost of cheaper generics accessed through publically funded programs. Furthermore, emerging markets previously targeted to drive revenue growth face potentially crippling consequences from the downturn.
Pharmiweb editor
06 Apr 09
Medical communications provide professional, valuable marketing solutions to pharmaceutical companies, incorporating; writing, design, multimedia, conferences and events and more.
Claire Phillpot
03 Apr 09
We have all heard the doom and gloom regarding the financial markets/ credit crunch/ recession. It’s pretty hard to escape it. The high earning bankers are jobless and the face of our high street is changing with high profile collapses of organisations including Woolworths, the Officers Club, MFI and Barretts.
Chantal Williams- RSA executive search consultant
03 Apr 09
It is perhaps fitting, if not entirely coincidental, that the month that we chose to focus on the important areas of the central nervous system and pain, also coincides with Multiple Sclerosis Awareness Month.
Max Golby
31 Mar 09
For some patients, namely those suffering from terminal illness, pain relief is an issue that talks to them about the right to end their lives in relative comfort and dignity. In such situations, new kinds of research that attack the complications and side effects of high level pain killers – such as opium based pain relievers – are particularly pertinent.
Max Golby
16 Mar 09
Adventis Health is one of a number of medical communications agencies that offers an integrated service with advertising, PR, Medical Education and digital media all available in house.
Adventis Health
11 Mar 09
In January, leading pharmaceutical experts attended the 2009 Forum Institute seminar on biosimilars, and the challenges involved in their successful development and launch. While the main focus of the meeting the biosimilars market in the EU, it was widely agreed that developments in the US, and President Obama's handling of the generic biotech issue, will be the defining issue of 2009 and beyond.
Editor
10 Mar 09
20 minutes preparation can make all the difference!
People don’t interview everyday! Lets face it, its not always easy. The purpose of this short article is to help you prepare fully for your interview.
Phlexglobal Ltd
10 Mar 09
Much has been written on how to produce a good CV so in this article, I will give you an insight as to how a recruiter uses a CV during the recruitment process.
Toni Lakin - Phlexglobal Ltd
10 Mar 09
Job satisfaction is an attitude that employees have about their work and is based on numerous factors, both intrinsic and extrinsic to the individual. Job satisfaction is important from the perspective of maintaining and retaining the appropriate employees within the organization; it is about fitting the right person to the right job in the right culture and keeping them satisfied.1,2
Toni Lakin - Phlexglobal Ltd
09 Mar 09
Drug Repositioning Strategies is a report that provides in-depth analysis of leading pharma companies that are using novel technologies to reposition failed, marketed or reformulated compounds.
Editor
09 Mar 09
Matt Greig at Advanced Regulatory provides an overview on *** Option Suisse *** and gives an introduction to working and living in Switzerland.
Matt Greig - Advanced Regulatory
05 Mar 09
A recent market analysis survey* into the employment trends and aspirations of clinical research professionals working in the Clinical Research sectors has confirmed the move and
willingness of people to consider independent contract based employment.
Rachel Corbishley - Redtree
03 Mar 09
Ice Bandage is the latest “must have” medicine cabinet essential for the first aid & topical analgesic categories. With its cooling properties and its metallic packaging, it will certainly stand out on shelf.
Claire Dunbar/Susan Leigh - Fuel PR
02 Mar 09
As one of the most preventable forms of death in the world today, obesity is widely regarded as one of the most serious public health concerns of the 21st century.
Max Golby
.jpg)
27 Feb 09
In Part Three of our four part commentary on the outlook for 2009, we discuss how the Federal government’s investment in comparative clinical effectiveness research is going to impact the pharmaceutical industry and shape reimbursement strategies for healthcare payers.
CBR Pharma Insights
